These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12619019)

  • 1. Should HCV-related cirrhosis be a contraindication for retransplantation?
    Biggins SW; Terrault NA
    Liver Transpl; 2003 Mar; 9(3):236-8. PubMed ID: 12619019
    [No Abstract]   [Full Text] [Related]  

  • 2. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retransplantation for recurrent hepatitis C: positive aspects.
    McCashland TM
    Liver Transpl; 2003 Nov; 9(11):S67-72. PubMed ID: 14586899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of hepatitis C virus in pediatric liver transplant recipients.
    Barshes NR; Udell IW; Lee TC; O'Mahony CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Jul; 12(7):1119-23. PubMed ID: 16799942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and management of hepatitis C in liver transplant recipients.
    Chan SE; Rosen HR
    Clin Infect Dis; 2003 Sep; 37(6):807-12. PubMed ID: 12955642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcome after hepatic retransplantation for hepatitis C virus-positive and -negative recipients.
    Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Romano J; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3159-61. PubMed ID: 16213336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal liver disease despite sustained eradication of recurrent hepatitis C virus requiring liver retransplantation.
    Mukherjee S
    Transplantation; 2006 Jul; 82(2):286-8. PubMed ID: 16858294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted.
    Verna EC; Brown RS
    Clin Liver Dis; 2008 Aug; 12(3):637-59, ix-x. PubMed ID: 18625432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of retransplantation for recurrent hepatitis C.
    Roayaie S; Schiano TD; Thung SN; Emre SH; Fishbein TM; Miller CM; Schwartz ME
    Hepatology; 2003 Dec; 38(6):1428-36. PubMed ID: 14647054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.
    Ghabril M; Dickson RC; Machicao VI; Aranda-Michel J; Keaveny A; Rosser B; Bonatti H; Krishna M; Yataco M; Satyanarayana R; Harnois D; Hewitt W; Willingham DD; Grewal H; Hughes CB; Nguyen J
    Liver Transpl; 2007 Dec; 13(12):1717-27. PubMed ID: 18044750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C.
    Burra P
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation.
    Ercolani G; Grazi GL; Ravaioli M; Del Gaudio M; Cescon M; Varotti G; Ramacciato G; Vetrone G; Zanello M; Pinna AD
    Liver Transpl; 2006 Jul; 12(7):1104-11. PubMed ID: 16710855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anonymous pilot study of hepatitis C virus prevalence in liver transplant surgeons.
    Thorburn D; Roy K; Wilson K; Stell D; Cameron S; Wall W; Mills PR; Goldberg D
    Liver Transpl; 2006 Jul; 12(7):1084-8. PubMed ID: 16799957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early HCV-associated stellate cell activation in aggressive recurrent HCV: what can liver allografts teach about HCV pathogenesis?
    Demetris AJ; Lunz JG
    Liver Transpl; 2005 Oct; 11(10):1172-6. PubMed ID: 16184566
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes.
    McCaughan GW; Shackel NA; Bertolino P; Bowen DG
    Transplantation; 2009 Apr; 87(8):1105-11. PubMed ID: 19384153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retransplantation for recurrent hepatitis C: the argument against.
    Wall WJ; Khakhar A
    Liver Transpl; 2003 Nov; 9(11):S73-8. PubMed ID: 14586900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo cryptogenic hepatitis after sustained eradication of hepatitis C following liver transplantation.
    Mukherjee S; Rogge J; Weaver LK; Schafer DF
    Transplant Proc; 2004 Jun; 36(5):1494-7. PubMed ID: 15251368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.